---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-24-000106"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:44:41.048806+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo Q3 healthcare revenue up 11.7% CC; raises FY non-GAAP EPS guidance to $3.95-$4.10

## Summary
- Healthcare revenue $343.3M (+11.7% CC); total revenue $504.6M; 60,500 board/instrument shipments.
- GAAP EPS $0.18; Non-GAAP EPS $0.98; GAAP operating income $30.1M, non-GAAP $80.8M.
- Raised FY2024 non-GAAP EPS guidance to $3.95-$4.10 from prior $3.80-$4.00; operating income $325-$336M.
- Narrowed FY total revenue guidance to $2.075-$2.105B from $2.085-$2.135B; healthcare $1.390-$1.400B.
- Interim CEO cites ongoing portfolio review, R&D focus on sizable markets, and strategic review of consumer business.

## SEC filing metadata
- accession: 0000937556-24-000106
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755624000106/0000937556-24-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755624000106/masi-20241105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-24-000106
- JSON: https://secwatch.observer/filing/0000937556-24-000106.json
- Plain text: https://secwatch.observer/filing/0000937556-24-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.